184 related articles for article (PubMed ID: 32520841)
1. Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel.
Lemaitre F; Vethe NT; D'Avolio A; Tron C; Robertsen I; De Winter B; Denicolo A; Koch BCP; Venkataramanan R; Van Gelder T; Brunet M; Bergan S; Hesselink DA; Wallemacq P
Ther Drug Monit; 2020 Oct; 42(5):665-670. PubMed ID: 32520841
[TBL] [Abstract][Full Text] [Related]
2. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation.
de Jonge H; Naesens M; Kuypers DR
Ther Drug Monit; 2009 Aug; 31(4):416-35. PubMed ID: 19536049
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M; van Gelder T; Åsberg A; Haufroid V; Hesselink DA; Langman L; Lemaitre F; Marquet P; Seger C; Shipkova M; Vinks A; Wallemacq P; Wieland E; Woillard JB; Barten MJ; Budde K; Colom H; Dieterlen MT; Elens L; Johnson-Davis KL; Kunicki PK; MacPhee I; Masuda S; Mathew BS; Millán O; Mizuno T; Moes DAR; Monchaud C; Noceti O; Pawinski T; Picard N; van Schaik R; Sommerer C; Vethe NT; de Winter B; Christians U; Bergan S
Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells.
Lemaitre F; Blanchet B; Latournerie M; Antignac M; Houssel-Debry P; Verdier MC; Dermu M; Camus C; Le Priol J; Roussel M; Zheng Y; Fillatre P; Curis E; Bellissant E; Boudjema K; Fernandez C
Clin Biochem; 2015 Apr; 48(6):406-11. PubMed ID: 25562187
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
6. Blood, Cellular, and Tissular Calcineurin Inhibitors Pharmacokinetic-Pharmacodynamic Relationship in Heart Transplant Recipients: The INTRACAR Study.
Coste G; Chabanne C; Tron C; Lelong B; Verdier MC; Roussel M; Le Gall F; Turlin B; Desille-Dugast M; Flécher E; Laviolle B; Lemaitre F
Ther Drug Monit; 2023 Apr; 45(2):229-235. PubMed ID: 36006706
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation.
Fu R; Tajima S; Suetsugu K; Watanabe H; Egashira N; Masuda S
Acta Pharmacol Sin; 2019 Feb; 40(2):151-159. PubMed ID: 29950613
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the use of Calcineurin inhibitors in liver transplantation.
de Mare-Bredemeijer EL; Metselaar HJ
Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
[TBL] [Abstract][Full Text] [Related]
9. [Summary of the recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on the therapeutic drug monitoring of tacrolimus].
Lemaitre F; Monchaud C; Woillard JB; Picard N; Marquet P
Therapie; 2020; 75(6):681-685. PubMed ID: 32653093
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Andrews LM; Li Y; De Winter BCM; Shi YY; Baan CC; Van Gelder T; Hesselink DA
Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1225-1236. PubMed ID: 29084469
[TBL] [Abstract][Full Text] [Related]
11. Individualizing calcineurin inhibitor therapy in renal transplantation--current limitations and perspectives.
Press RR; de Fijter JW; Guchelaar HJ
Curr Pharm Des; 2010; 16(2):176-86. PubMed ID: 20205663
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.
Albring A; Wendt L; Harz N; Engler H; Wilde B; Kribben A; Lindemann M; Schedlowski M; Witzke O
Clin Transplant; 2015 Apr; 29(4):294-300. PubMed ID: 25557538
[TBL] [Abstract][Full Text] [Related]
13. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin Inhibitor Toxicity in Solid Organ Transplantation.
Karolin A; Genitsch V; Sidler D
Pharmacology; 2021; 106(7-8):347-355. PubMed ID: 34130291
[TBL] [Abstract][Full Text] [Related]
15. The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?
Farouk SS; Rein JL
Adv Chronic Kidney Dis; 2020 Jan; 27(1):56-66. PubMed ID: 32147003
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
Ann Transplant; 2014 Jan; 19():32-40. PubMed ID: 24457606
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic concentrations of calcineurin inhibitors do not deregulate glutathione redox balance in human renal proximal tubule cells.
Ramazani Y; Knops N; Berlingerio SP; Adebayo OC; Lismont C; Kuypers DJ; Levtchenko E; van den Heuvel LP; Fransen M
PLoS One; 2021; 16(4):e0250996. PubMed ID: 33930094
[TBL] [Abstract][Full Text] [Related]
18. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
[TBL] [Abstract][Full Text] [Related]
19. Optimizing everolimus exposure when combined with calcineurin inhibitors in solid organ transplantation.
van Gelder T; Fischer L; Shihab F; Shipkova M
Transplant Rev (Orlando); 2017 Jul; 31(3):151-157. PubMed ID: 28279567
[TBL] [Abstract][Full Text] [Related]
20. The impact of calcineurin inhibitors on graft survival.
Rush D
Transplant Rev (Orlando); 2013 Jul; 27(3):93-5. PubMed ID: 23743217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
